Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience (Front. Neurol., (2021), 12, 10.3389/fneur.2021.628077)

Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study Group

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

In the published article, there were errors in affiliations 1–5. Instead of “1 School of Public Health, College of Public Health, Taipei, Taiwan, 2 Beijing Tiantan Hospital, Capital Medical University, Beijing, China, 3 Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, 4 Department of Neurology, Taipei Medical University-Shaung Ho Hospital, Taipei, Taiwan, 5 Department of Health Care Administration, Chung-Hwa University of Medical Technology, Tainan, Taiwan” it should be “1 School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan, 2 Department of Critical Care Medicine, Taipei Medical University Hospital, Taipei, Taiwan, 3 Department of Clinical Pathology, Taipei Medical University, Taipei, Taiwan, 4 Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China, 5 Department of Neurology, Taipei Medical University-Shaung Ho Hospital, Taipei, Taiwan.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Original languageEnglish
Article number737437
JournalFrontiers in Neurology
Volume12
DOIs
Publication statusPublished - Sep 17 2021

Keywords

  • aspirin
  • clopidogrel
  • intracranial hemorrhage
  • intravenous thrombolysis
  • stroke

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Corrigendum: Pre-treatment of Single and Double Antiplatelet and Anticoagulant With Intravenous Thrombolysis for Older Adults With Acute Ischemic Stroke: The TTT-AIS Experience (Front. Neurol., (2021), 12, 10.3389/fneur.2021.628077)'. Together they form a unique fingerprint.

Cite this